Key result
Statin therapy is linked to substantially lower sepsis incidence in hospitalized cardiovascular disease patients.
Why the study?
Statins reduce infection and sepsis incidence, contributing to decreased mortality and morbidity in patients with cardiovascular and atherosclerotic disease, but this benefit is underrecognized.
Answers are grounded in this paper and cite their sources.
Statin use was associated with lower perioperative infection and sepsis; hypothesis-generating and should not yet change practice.
To the Editor: The recent editorial by Sethi and Collard described beneficial effects of statins in decreasing surgical morbidity and mortality.1 In addition to direct cholesterol reduction and pleiotropic effects, which include antiatherosclerotic, antithrombotic, antiinflammatory, antioxidant, and endothelial stabilizing properties, statins also reduce the incidence of infection and sepsis, which, in turn, contributes to decreased mortality and morbidity in patients with cardiovascular and atherosclerotic disease.2–4 A pivotal population-based cohort study, the largest of its kind so far, 141,487 patients hospitalized for an acute coronary syndrome, ischemic stroke, or arterial revascularization and survived ≥3 mo after discharge, found that the incidence of sepsis was substantially lower among patients receiving statin therapy than controls.3 This protective association between statins and sepsis persisted in high risk subgroups, including patients with diabetes mellitus, chronic renal failure, chronic liver disease, malignancy, or those with history of recurrent infections. Atherosclerosis and sepsis share several pathophysiologic similarities, including immune dysregulation, increased thrombogenesis, and systemic inflammation. Therefore, it is not surprising to find beneficial effects of statins in patients with sepsis.3,4 Pretreatment in animals with statins leads to substantial reductions in inflammatory cytokines and activation of immune cells, findings which have since been replicated in human studies.5–7 Additionally, statins appear to decrease the overproduction of nitric oxide implicated in the vasodilatation and circulatory collapse of septic shock.5,8 Beneficial effects of statins in sepsis have also been attributable to their antioxidant and anticoagulant properties.9,10 Therefore, prevention of sepsis and reduced risk of infection-related mortality in patients with atherosclerotic and cardiovascular disease seems to be a major advantage of statins and should have been discussed by Sethi and Collard in their editorial, an important preamble/ preface to the landmark trial by Le Menach et al.11 Rajesh Mahajan, MBBS, MD Assistant Professor Department of Anaesthesia ASCOMS Jammu, J&K [email protected]
No takes yet. Share an insight, caveat, or question.
Mahajan et al. (2008) conducted a letter in Atherosclerotic and cardiovascular disease (n=141,487). Statin therapy vs. Controls was evaluated on Incidence of sepsis. Statin therapy was associated with a substantially lower incidence of sepsis compared to controls among patients hospitalized for cardiovascular and atherosclerotic disease.
Synapse has enriched 10 related papers. Consider them for comparative context: